Energy And Related Services Tenders

Miac Summary Report October 2022

Passenger Transport Services

Ruth L. Kirschstein National Research Service Award (Nrsa) Short-Term Institutional Research Training Grant (Parent T35)

Open House Drug Discount Agreements Colecalciferol, Non Rx, only Products that can be Prescribed According to Annex 1 Am-Rl G-Ba, Atc A11cc05

Open House Drug Rebate Agreements Everolimus, Atc L04aa18 and Everolimus as Off-Patent Oncology Indications not Related to Tuberous Sclerosis (Tsc), Atc L01eg02

Conclusion of Non-Exclusive Discount Agreements in Accordance with §§ 130A Paragraph 8/130C Paragraph 1 Sgb V for Drugs with the Active Ingredient Ivermectin (P02cf01) as Part of a So-Called Open House Model.

Conclusion of Non-Exclusive Discount Agreements in Accordance with §§ 130A Para. 8/130C Para. 1 Sgb V for Drugs with the Active Ingredient Iron(Iii) Oxide-Sucrose Complex (B03ac02) as Part of an Open-House Model.

Conclusion of Non-Exclusive Discount Agreements in Accordance with §§ 130A Paragraph 8/130C Paragraph 1 Sgb V for Drugs with the Active Ingredient Albendazole (P02ca03) as Part of a So-Called Open House Model.

Conclusion of Non-Exclusive Discount Agreements in Accordance with §§ 130A Paragraph 8/130C Paragraph 1 Sgb V for Drugs with the Active Ingredient Trientine (A16ax12) as Part of a So-Called Open House Model.

Conclusion of Non-Exclusive Discount Agreements in Accordance with §§ 130A Paragraph 8/130C Paragraph 1 Sgb V for Drugs with the Active Ingredient Ritonavir (J05ae03) as Part of a So-Called Open House Model.